Cliff Asness's MIRM Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 89,164 shares of Mirum Pharmaceuticals, Inc. (MIRM) worth $7.62 M, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in MIRM, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 60,517 shares. Largest reduction occurred in Q2 2024, reducing 23,721 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Mirum Pharmaceuticals (MIRM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Mirum Pharmaceuticals (MIRM) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +60,517 | Add 211.25% | 89,164 | $85.48 |
| Q2 2026 | -3,144 | Reduce 9.89% | 28,647 | $117.07 |
| Q1 2026 | -694 | Reduce 2.14% | 31,791 | $92.38 |
| Q4 2025 | +1,090 | Add 3.47% | 32,485 | $78.99 |
| Q3 2025 | -16,121 | Reduce 33.93% | 31,395 | $73.31 |
| Q2 2025 | -1,560 | Reduce 3.18% | 47,516 | $50.89 |
| Q1 2025 | +37,028 | Add 307.34% | 49,076 | $45.05 |
| Q4 2024 | -497 | Reduce 3.96% | 12,048 | $41.35 |
| Q3 2024 | +4,251 | Add 51.25% | 12,545 | $39.00 |
| Q2 2024 | -23,721 | Reduce 74.09% | 8,294 | $34.19 |
| Q1 2024 | +19,139 | Add 148.64% | 32,015 | $25.12 |
| Q4 2023 | -2,667 | Reduce 17.16% | 12,876 | $29.52 |
| Q3 2023 | +3,317 | Add 27.13% | 15,543 | $31.60 |
| Q2 2023 | -2,320 | Reduce 15.95% | 12,226 | $25.87 |
| Q1 2023 | +247 | Add 1.73% | 14,546 | $24.02 |
| Q4 2022 | +3,579 | Add 33.39% | 14,299 | $19.50 |
| Q3 2022 | +10,720 | New Buy | 10,720 | $20.99 |
Cliff Asness's Mirum Pharmaceuticals Investment FAQs
Cliff Asness first purchased Mirum Pharmaceuticals, Inc. (MIRM) in Q3 2022, acquiring 10,720 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Mirum Pharmaceuticals, Inc. (MIRM) for 17 quarters since Q3 2022.
Cliff Asness's largest addition to Mirum Pharmaceuticals, Inc. (MIRM) was in Q3 2026, adding 89,164 shares worth $7.62 M.
According to the latest 13F filing for Q3 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 89,164 shares of Mirum Pharmaceuticals, Inc. (MIRM), valued at approximately $7.62 M.
As of the Q3 2026 filing, Mirum Pharmaceuticals, Inc. (MIRM) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Mirum Pharmaceuticals, Inc. (MIRM) was 89,164 shares, as reported at the end of Q3 2026.